Page last updated: 2024-08-16

wb 4101 and acetazolamide

wb 4101 has been researched along with acetazolamide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Angeli, A; Artasensi, A; Baron, G; Bollati, C; Fumagalli, L; Gervasoni, S; Lammi, C; Matucci, R; Supuran, CT; Vistoli, G	1

Other Studies

1 other study(ies) available for wb 4101 and acetazolamide

Article	Year
Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101. Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20 Topics: Adrenergic Agents; Caco-2 Cells; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Ligands	2022

Article

Year

Discovery of a Potent and Highly Selective Dipeptidyl Peptidase IV and Carbonic Anhydrase Inhibitor as "Antidiabesity" Agents Based on Repurposing and Morphing of WB-4101.

Journal of medicinal chemistry, 2022, 10-27, Volume: 65, Issue:20

Topics: Adrenergic Agents; Caco-2 Cells; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Humans; Hypoglycemic Agents; Ligands

2022